Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia
ClinicalTrials.gov study NCT00440154. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Black Cohosh Extract for the Management of Moderate to Severe Menopausal Symptoms in Thai Women
ClinicalTrials.gov study NCT01487694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chronic Moderate Sleep Restriction in Older Adults
ClinicalTrials.gov study NCT01642719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
ClinicalTrials.gov study NCT02492321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
ClinicalTrials.gov study NCT06802848. IPD Sharing: NO. Countries: 1. Publications: 0.
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)
ClinicalTrials.gov study NCT06160908. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia
ClinicalTrials.gov study NCT04679415. IPD Sharing: NO. Countries: 1. Publications: 0.
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT07122076. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)
ClinicalTrials.gov study NCT00315718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00675623. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intra- and Interindividual Moderators of Prefrontal Excitability Investigated Using Simultaneous TMS With Neuroimaging
ClinicalTrials.gov study NCT06976879. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of Moderate to Severe Refractory Crohn's Disease
ClinicalTrials.gov study NCT06721962. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety
ClinicalTrials.gov study NCT05562739. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00100334. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
ClinicalTrials.gov study NCT01164904. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease
ClinicalTrials.gov study NCT03677648. IPD Sharing: NO. Countries: 4. Publications: 0.
Mediators and Moderators of Auditory Training
ClinicalTrials.gov study NCT06812273. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.
ClinicalTrials.gov study NCT04900337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)
ClinicalTrials.gov study NCT03108664. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris
ClinicalTrials.gov study NCT04163263. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.